[Summary] 开发变革性的肿瘤免疫治疗药物,造福全世界的癌症患者
科望医药是一家处于临床阶段的生物医药公司,致力于开发变革性的肿瘤免疫治疗药物,旨在造福全世界的癌症患者。公司的创新聚焦在肿瘤微环境的研究,探索和验证更有效的杀伤肿瘤的机制。基于自主开发的专利平台,科望医药已建立起全球创新的肿瘤免疫治疗产品管线,凭借自身卓越的研发能力和与国际生物医药企业的创新合作,科望医药持续努力将具有突破性价值的创新候选药物推进到临床。
Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies fcancer patients worldwide. The company’s innovative approach is focused on targeting tummicroenvironment to identify effective mechanisms to kill cancer. A pipeline of novel molecules has been developed using its proprietary platforms. Through internal R&D expertise partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance the programs with breakthrough value clinic use.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows